Sutro Biopharma, Inc.
STRO
$0.81
$0.00470.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 248.97M | 316.90M | 388.25M | 425.99M | 313.22M |
| Total Receivables | 13.56M | 8.62M | 6.66M | 6.95M | 31.30M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 24.88M | 17.80M | 10.87M | 10.53M | 10.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 287.41M | 343.31M | 405.78M | 443.48M | 354.58M |
|
|
|||||
| Total Current Assets | 287.41M | 343.31M | 405.78M | 443.48M | 354.58M |
| Net Property, Plant & Equipment | 33.08M | 35.87M | 38.02M | 39.75M | 42.22M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 943.00K | 8.03M | 8.03M | 5.82M | 6.60M |
| Total Assets | 321.43M | 387.21M | 451.83M | 489.04M | 403.40M |
|
|
|||||
| Total Accounts Payable | 8.18M | 10.48M | 6.22M | 6.09M | 7.51M |
| Total Accrued Expenses | 33.95M | 40.13M | 41.83M | 39.41M | 26.25M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.77M | 7.48M | 7.20M | 6.93M | 6.67M |
| Total Finance Division Other Current Liabilities | 83.15M | 73.81M | 76.04M | 77.56M | 39.07M |
| Total Other Current Liabilities | 83.15M | 73.81M | 76.04M | 77.56M | 39.07M |
| Total Current Liabilities | 133.05M | 131.89M | 131.29M | 129.99M | 79.51M |
|
|
|||||
| Total Current Liabilities | 133.05M | 131.89M | 131.29M | 129.99M | 79.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 13.63M | 15.67M | 17.66M | 19.59M | 21.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 200.56M | 195.04M | 191.66M | 187.29M | 204.47M |
| Total Liabilities | 347.24M | 342.61M | 340.61M | 336.87M | 305.38M |
|
|
|||||
| Common Stock & APIC | 837.04M | 831.43M | 825.54M | 817.98M | 715.76M |
| Retained Earnings | -862.84M | -786.87M | -714.43M | -665.64M | -617.62M |
| Treasury Stock & Other | -9.00K | 39.00K | 106.00K | -163.00K | -113.00K |
| Total Common Equity | -25.81M | 44.60M | 111.22M | 152.18M | 98.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.81M | 44.60M | 111.22M | 152.18M | 98.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.81M | 44.60M | 111.22M | 152.18M | 98.02M |
|
|
|||||